LCR
WELCOME!
ABOUT LCR
COLOSTRUM INFO
FAQ's
RESEARCH
HEALTH
COMPONENTS
ARTICLES
BOOKS
CONTACT
NEW ZEALAND LINKS
NEW ZEALAND COLOSTRUM
about articles
001 Athletics and Heavy resistance. 002 Digestive. 003 Cessation of Cryptosporidium-associated diarrhea in an acquired immunodeficiency syndrome patient after treatment with hyperimmune bovine colostrum. 004 Concentrated bovine colostral whey proteins from Streptococcus mutans/Strep. sobrinus immunized cows inhibit the adherence of Strep. mutans and promote the aggregation of mutans streptococci. 005 Cessation of Cryptosporidium-associated diarrhea in an acquired immunodeficiency syndrome patient after treatment with hyperimmune bovine colostrum. 006 Treatment of Helicobacter pylori infection in infants in rural Bangladesh with oral immunoglobulins from hyperimmune bovine colostrum. 007 Promoting effect of colostrum on the phagocytic activity of bovine polymorphonuclear leukocytes in vitro. 008 Successful hyperimmune bovine colostrum treatment of Savanna monitors (Varanus exanthematicus) infected with Cryptosporidium sp. 009 Characterization of a > 900,000-M(r) Cryptosporidium parvum sporozoite glycoprotein recognized by protective hyperimmune bovine colostral immunoglobulin 010 Fatty acid composition of human colostrum and mature breast milk. 011 Enzymic characteristics of fat globule membranes from bovine colostrum and bovine milk. 012 The Protective Effects of Lactoferrin Feeding against Endotoxin Lethal Shock in Germfree Piglets . 013 Co-administration of the health food supplement, bovine colostrum, reduces the acute non-steroidal anti-inflammatory drug-induced increase in intestinal permeability. 014 Gastrointestinal Tract - Survival of rotavirus antibody activity derived from bovine colostrum after passage through the human gastrointestinal tract. 015 Colostrum and milk-derived peptide growth factors for the treatment of gastrointestinal disorders. 016 Protection by milk immunoglobulin concentrate against oral challenge with enterotoxigenic Escherichia coli. 017 Bovine colostrum immunoglobulin concentrate for cryptosporidiosis in AIDS 018 Biological activities of bovine glycomacropeptide. 019 Nonnutritive Factors in Colostrum Enhance Myofibrillar Protein Synthesis in the Newborn Pig . 020 In vivo antimicrobial and antiviral activity of components in bovine milk and colostrum involved in non-specific defence. 021 Suckling Induces Rapid Intestinal Growth and Changes in Brush Border Digestive Functions of Newborn Pigs. 022 Inhibition of S-fimbria-mediated adhesion to human ileostomy glycoproteins by a protein isolated from bovine colostrum. 023 Nucleosides and nucleotides: natural bioactive substances in milk and colostrum. 024 Fatty Acids. 025 Bone and Joint Disease. 026 Gut Health. 027 Rotaviral antibodies in the treatment of acute rotaviral gastroenteritis. 028 Development of the newborn GI tract and its relation to colostrum/milk intake: a review. 029 Human milk and intestinal host defense in newborns: an update. 030 Sialic acid in breast milk and infant formula food. 031 New Insights into the Utilization of Medium-Chain Triglycerides by the Neonate: Observations from a Piglet Model. 032 A Comparison of IgG and IgG1 Activity in an Early Milk Concentrate from Non-Immunised Cows and a Milk from Hyperimmunised Animals. 033 Physical Activity and Cancer. 034 Concentrated bovine colostral whey proteins from Streptococcus mutans/Strep. sobrinus immunized cows inhibit the adherence of Strep. mutans and promote the aggregation of mutans streptococci. 035 Bovine milk antibodies for health 036 Effect of growth factors on cell proliferation and epithelialization in human skin. 037 The effects of bovine colostrum supplementation on body composition and exercise performance in active men and women. 038 2000 Pre-Olympic Congress 039 Sport Dietry Supplements Update 040 Growth factors and cytokines in bone cell metabolism 041 Increase in Gut Permeability 042 Bovine colostrum ameliorates diarrhea 043 Effects of oral bovine colostrum supplementation 044 Modulation of the immune system and the response against pathogens with bovine colostrum concentrates. 045 IGF-I, IgA, and IgG responses to bovine colostrum supplementation during training. 046 Pasteurization 047 Glutathione and Colostrum 048 Effects of orally administered bovine lactoferrin on the immune system of healthy volunteers. 049 Lactoferrin Levels 050 Bovine lactoferrin and lactoferricin derived from milk: production and applications. 051 Growth inhibitory effect of bovine lactoferrin 052 Milk and dairy products in cancer prevention 053 Composition of Colostrum and Feeding Duration 054 The Neonate and Colostrum 055 The Demographics of neo natal mortality 056 Sports Dietary Supplement and Colostrum 057 Influence of Cross-fostering on Piglet Growth and Survival 058 Neonatal Mortality and Weaning Weight 059 Treatment of multiple sclerosis with anti-measles cow colostrum 060 Management Tips To Reduce Pre-weaning Mortality 061 Effect of an oral bovine colostrum supplement (intact TM ) on running performance 062 Human Colostrum IgA Antibodies and Enteropathogenic Escherichia coli Antigens 063 Care of Pigs From Farrowing to Weaning 064 Bovine colostrum ameliorates diarrhea 065 Lactoperoxidase 066 Oligosaccharides and glycoconjugates in bovine milk and colostrum 067 Vivo antimicrobial and antiviral activity 068 Lactoferrin and its biological functions 070 Growth factors and cytokines in bone cell metabolism 071 Treatment of multiple sclerosis with anti-measles cow colostrum 072 Gastrointestinal injury and colostrum 073 Bovine colostrum supplementation on body composition and exercise performance 074 Increased bacterial urease activity in faeces in juvenile chronic arthritis: evidence of altered intestinal microflora 075 Effect of androgens on the brain and other organs during development and aging. 076 Colostrum and milk-derived peptide growth factors for the treatment of gastrointestinal disorders 077 Enhancement of Immunity in the Elderly by Dietary Supplementation with the Probiotic Bifidobacterium lactis HN0191 078 Bovine colostrum supplementation enhances physical performance on maximal exercise tests 079 Effects of oral bovine colostrum supplementation on serum insulin-like growth factor-i levels 080 Effects of orally administered bovine lactoferrin on the immune system of healthy volunteers 081 Bovine lactoferrin and lactoferricin derived from milk: production and applications 082 Growth inhibitory effect of bovine lactoferrin to Toxoplasma gondii tachyzoites in murine macrophages 083 Feeding Colostrum, Its Composition and Feeding Duration Variably Modify Proliferation and Morphology of the Intestine and Digestive Enzyme Activities of Neonatal Calves 084 Nonnutritive Factors in Colostrum Enhance Myofibrillar Protein Synthesis in the Newborn Pig 085 The Protective Effects of Lactoferrin Feeding against Endotoxin Lethal Shock in Germfree Piglets 086 Inhibition of S-fimbria-mediated adhesion to human ileostomy glycoproteins by a protein isolated from bovine colostrum 087 Bovine colostrum immunoglobulin concentrate for cryptosporidiosis in AIDS 088 Characterization of a > 900,000-M(r) Cryptosporidium parvum sporozoite glycoprotein recognized by protective hyperimmune bovine colostral immunoglobulin 089 Essential fatty acid composition of human colostrum triglycerides: its relationship with adipose tissue composition 090 Cessation of Cryptosporidium-associated diarrhea in an acquired immunodeficiency syndrome patient after treatment with hyperimmune bovine colostrum 091 Protection by milk immunoglobulin concentrate against oral challenge with enterotoxigenic Escherichia coli 092 Suckling Induces Rapid Intestinal Growth and Changes in Brush Border Digestive Functions of Newborn Pigs 093 Fatty acid composition of human colostrum and mature breast milk 094 Enzymic characteristics of fat globule membranes from bovine colostrum and bovine milk 095 Milk and dairy products in cancer prevention: focus on bovine lactoferrin 096 Immune response of pregnant heifers and cows to bovine rotavirus inoculation. 097 Vaccination studies against experimental bovine Pasteurella pneumonia 098 The Demographics of Neonatal Mortality and the Benefits of Crossfostering 099 Farrowing Management and Piglet Losses 100 Nonnutritive Factors in Colostrum Enhance Myofibrillar Protein Synthesis in the Newborn Pig 101 Comparison of the gastrointestinal growth 102 Colostrum and milk-derived peptide growth factors for the treatment of gastrointestinal disorders 103 Vitamin E, lipid fractions, and fatty acid composition of colostrum, transitional milk, and mature milk: an international comparative study 104 Effect of maternal nutritional status on immunological substances in human colostrum and milk 105 Microparticle-enhanced nephelometric immunoassay of lysozyme in milk and other human body fluids 106 Effect of extra N-terminal residues on the stability and folding of human lysozyme expressed in Pichia pastoris 107 The evolution of lysozyme and alpha-lactalbumin 108 Lysozyme, lactoferrin, and secretory immunoglobulin A content in breast milk: influence of duration of lactation, nutrition status, prolactin status, and parity of mother 109 Serum lysozyme: evaluation of a nephelometric assay. 110 Radioimmunoassay for urinary lysozyme in human serum from leukemic patients 111 Measurement of lysozyme by an enzyme-linked immunosorbent assay 112 Immunochemical determination of human lysozyme by laser nephelometry 113 Limitations of conventional laser nephelometry for the measurement of beta 2-microglobulin, lysozyme, alpha 1 fetoprotein and myoglobin in serum and urine 114 Microparticle-enhanced nephelometric immunoassay of alpha-lactalbumin in human milk 115 Measurement of beta-casein in human milk by microparticle-enhanced nephelometric immunoassay 116 Microparticle-enhanced nephelometric immunoassay (Nephelia) for immunoglobulins G, A, and M 117 Measurement of lysozyme in human body fluids 118 Viral Load in Breast Milk Correlates with Transmission of Human Cytomegalovirus to Preterm Neonates, but Lactoferrin Concentrations Do Not 119 Antiviral effects of plasma and milk proteins 120 Synergistic Fungistatic Effects of Lactoferrin in Combination with Antifungal Drugs against Clinical Candida Isolates 121 Lactoferrin: a general review 122 Lactoferrin: Molecular Structure and Biological Function 123 In vitro antiviral activity of lactoferrin and ribavirin upon hantavirus
001
Athletics and Heavy resistance.
002
Digestive.
003
Cessation of Cryptosporidium-associated diarrhea in an acquired immunodeficiency syndrome patient after treatment with hyperimmune bovine colostrum.
004
Concentrated bovine colostral whey proteins from Streptococcus mutans/Strep. sobrinus immunized cows inhibit the adherence of Strep. mutans and promote the aggregation of mutans streptococci.
005
006
Treatment of Helicobacter pylori infection in infants in rural Bangladesh with oral immunoglobulins from hyperimmune bovine colostrum.
007
Promoting effect of colostrum on the phagocytic activity of bovine polymorphonuclear leukocytes in vitro.
008
Successful hyperimmune bovine colostrum treatment of Savanna monitors (Varanus exanthematicus) infected with Cryptosporidium sp.
009
Characterization of a > 900,000-M(r) Cryptosporidium parvum sporozoite glycoprotein recognized by protective hyperimmune bovine colostral immunoglobulin
010
Fatty acid composition of human colostrum and mature breast milk.
011
Enzymic characteristics of fat globule membranes from bovine colostrum and bovine milk.
012
The Protective Effects of Lactoferrin Feeding against Endotoxin Lethal Shock in Germfree Piglets .
013
Co-administration of the health food supplement, bovine colostrum, reduces the acute non-steroidal anti-inflammatory drug-induced increase in intestinal permeability.
014
Gastrointestinal Tract - Survival of rotavirus antibody activity derived from bovine colostrum after passage through the human gastrointestinal tract.
015
Colostrum and milk-derived peptide growth factors for the treatment of gastrointestinal disorders.
016
Protection by milk immunoglobulin concentrate against oral challenge with enterotoxigenic Escherichia coli.
017
Bovine colostrum immunoglobulin concentrate for cryptosporidiosis in AIDS
018
Biological activities of bovine glycomacropeptide.
019
Nonnutritive Factors in Colostrum Enhance Myofibrillar Protein Synthesis in the Newborn Pig .
020
In vivo antimicrobial and antiviral activity of components in bovine milk and colostrum involved in non-specific defence.
021
Suckling Induces Rapid Intestinal Growth and Changes in Brush Border Digestive Functions of Newborn Pigs.
022
Inhibition of S-fimbria-mediated adhesion to human ileostomy glycoproteins by a protein isolated from bovine colostrum.
023
Nucleosides and nucleotides: natural bioactive substances in milk and colostrum.
024
Fatty Acids.
025
Bone and Joint Disease.
026
Gut Health.
027
Rotaviral antibodies in the treatment of acute rotaviral gastroenteritis.
028
Development of the newborn GI tract and its relation to colostrum/milk intake: a review.
029
Human milk and intestinal host defense in newborns: an update.
030
Sialic acid in breast milk and infant formula food.
031
New Insights into the Utilization of Medium-Chain Triglycerides by the Neonate: Observations from a Piglet Model.
032
A Comparison of IgG and IgG1 Activity in an Early Milk Concentrate from Non-Immunised Cows and a Milk from Hyperimmunised Animals.
033
Physical Activity and Cancer.
Influence of Cross-fostering on Piglet Growth and Survival
(C) Copyright 2003 Laboratory of Colostrum Research, All Rights Reserved
P O Box:51-017, Pakuranga, Auckland, New Zealand